Medivolve

Zitat:"TORONTO, April 07, 2020 (GLOBE NEWSWIRE) --QuestCap Inc. (“QuestCap” or the “Company”) (CSE: QSC; FRA: 34C1) announced today that it has entered into a profit sharing agreement with More Than Just Rice, Inc. (“MTJR”), subject to the satisfaction of conditions with a Korean diagnostic testing company, for MTJR to exclusively distribute, market and sell COVID19 Antibody Tests in North and South America.   The  test  will  be  marketed/distributed  in  the  United  States  pursuant  to  the  U.S.  Food  and  Drug  Administration  (FDA)’s  policy  on  COVID-19 serological tests during the public health emergency period.COVID-19 Antibody Test Disclaimers:.......... test has not been reviewed by the FD.........negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.............Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.........Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E..........